Key facts
- This page summarizes Pamela Ann Connealy's Form 4 filing for Pyxis Oncology, Inc. (PYXS).
- 2 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 27 Nov 2024, 17:09.
Pamela Ann Connealy - 26 Nov 2024 Form 4 Insider Report for Pyxis Oncology, Inc. (PYXS)
- Reporting relationship
- CFO & COO
- Issuer ticker
- PYXS
- Reported as of
- 26 Nov 2024
- Net transaction value
- +$174,364
- SEC form
- 4
- Accepted by SEC
- 27 Nov 2024, 17:09:59 UTC
- Prior SEC filing
- 21 Jun 2024
- Next SEC filing
- 23 Dec 2024
- Source filing
- View source filing
- Reporting owner signature
- /s/ Pamela Connealy
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Pamela Ann Connealy filed Form 4 for Pyxis Oncology, Inc. (PYXS) on 27 Nov 2024.
Change
- Previous filing in this sequence was filed on 21 Jun 2024.
- Current net transaction value: +$174,364.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
PYXS
transaction
Common Stock
Purchase
- Transaction value
- $10,900
- Shares
- +5,450
- Change %
- +0.49%
- Price
- $2.00
- Shares after
- 1,115,743
- Date
- 26 Nov 2024
- Ownership
- By Trust
- Footnotes
- F1
PYXS
transaction
Common Stock
Purchase
- Transaction value
- $163,464
- Shares
- +83,400
- Change %
- +7.5%
- Price
- $1.96
- Shares after
- 1,199,143
- Date
- 26 Nov 2024
- Ownership
- By Spouse
- Footnotes
- F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
These shares are held directly by the Personal Def Ben Pln Trust, a revocable trust for which the Reporting Person and their spouse are the trustees.
Footnote F2
The price reported in column 4 is a weighted-average price.These shares were purchased in multiple transactions at prices ranging from $1.93 to $1.99, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth herein.